Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications

DNA and Cell Biology

Volumn 34, Issue 6, 2015, Pages 437-457

  Hromadnikova, Ilona ^a   Kotlabova, Katerina ^a   Ondrackova, Marketa ^a   Pirkova, Petra ^a   Kestlerova, Andrea ^a   Novotna, Veronika ^a   Hympanova, Lucie ^a   Krofta, Ladislav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 512; MICRORNA 515; MICRORNA 516; MICRORNA 517; MICRORNA 518B; MICRORNA 519A; MICRORNA 519D; MICRORNA 519E; MICRORNA 520A; MICRORNA 524; MICRORNA 525; MICRORNA 526A; MICRORNA 526B; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSCRIPTOME;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; CHROMOSOME 19; GENETICS; MALE; METABOLISM; MULTIGENE FAMILY; PREGNANCY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; BIOMARKERS; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MALE; MICRORNAS; MULTIGENE FAMILY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; TRANSCRIPTOME; YOUNG ADULT;

EID: 84930419197     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2687     Document Type: Article

References (102)

1. Abdulsid, A., Hanretty, K., and Lyall, F. (2013). Heat shock protein 70 expression is spatially distributed in human placenta and selectively upregulated during labor and preeclampsia. PLoS One 8, e54540.
2. Acar, N., Soylu, H., Edizer, I., Ozbey, O., Er, H., Akkoyunlu, G., Gemici, B., and Ustunel, I. (2014). Expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxiredoxin 6 (Prdx6) proteins in healthy and pathologic placentas of human and rat. Acta Histochem 116, 1289-300.
3. ACOG Committee on Practise Bulletins-Obstetrics. (2002). Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99, 159-167.
4. Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., and Nicolaides, K.H. (2011). Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31, 66-74.
5. Arbeille, P., Berson, M., Blondeau, B., Durand, A., Bodard, S., and Locatelli, A. (1995). Quantification and monitoring of vascular resistance in the lower limbs by the Doppler method (animal model). Arch Mal Coeur Vaiss 88, 1029-1034.
6. Bamfo, J.E., and Odibo, A.O. (2011). Diagnosis and management of fetal growth restriction. J Pregnancy 2011, 640715.
7. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
8. Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., Sharon, E., Spector, Y., and Bentwich, Z. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37, 766-770.
9. Bortolin-Cavaillé, M.L., Dance, M., Weber, M., and Cavaillé, J. (2009). C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res 37, 3464-3473.
10. Cali, U., Cavkaytar, S., Sirvan, L., and Danisman, N. (2013). Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2. Clin Exp Obstet Gynecol 40, 45-48.
11. Calin, G.A., and Croce, C.M. (2006). MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25, 6202-6210.
12. Chan, Y.C., Banerjee, J., Choi, S.Y., and Sen, C.K. (2012). miR-210: the master hypoxamir. Microcirculation 19, 215-223.
13. Chaparro, A., Blanlot, C., Ramírez, V., Sanz, A., Quintero, A., Inostroza, C., Bittner, M., Navarro, M., and Illanes, S.E. (2013). Porphyromonas gingivalis, Treponema denticola and toll-like receptor 2 are associated with hypertensive disorders in placental tissue: a case-control study. J Periodontal Res 48, 802-809.
14. Chatterjee, P., Weaver, L.E., Doersch, K.M., Kopriva, S.E., Chiasson, V.L., Allen, S.J., Narayanan, A.M., Young, K.J., Jones, K.A., Kuehl, T.J., and Mitchell, B.M. (2012). Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS One 7, e41884.
15. Chen, L.M., Liu, B., Zhao, H.B., Stone, P., Chen, Q., and Chamley, L. (2010). IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta 31, 75-80.
16. Chen, Q., Stone, P., Ching, L.M., and Chamley, L. (2009). A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia. J Pathol 217, 122-130.
17. Cruz-Martinez, R. (2009). The role of Doppler and placental screening. Best Pract Res Clin Obstet Gynaecol 23, 845-855.
18. Dahlstrøm, B., Esbensen, Y., Vollan, H., Oian, P., and Bukholm, G. (2010). Genome profiles in maternal blood during early onset preeclampsia and towards term. J Perinat Med 38, 601-608.
19. Díaz, E., Cárdenas, M., Ariza, A.C., Larrea, F., and Halhali, A. (2005). Placental insulin and insulin-like growth factor I receptors in normal and preeclamptic pregnancies. Clin Biochem 38, 243-247.
20. Dubova, E.A., Pavlov, K.A., Lyapin, V.M., Shchyogolev, A.I., and Sukhikh, G.T. (2013). Vascular endothelial growth factor and its receptors in the placental villi of pregnant patients with pre-eclampsia. Bull Exp Biol Med 154, 792-795.
21. Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011). miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44, 839-847.
22. Enquobahrie, D.A., Abetew, D.F., Sorensen, T.K., Willoughby, D., Chidambaram, K., and Williams, M.A. (2011). Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204, 178.e112-e121.
23. Fan, X., Rai, A., Kambham, N., Sung, J.F., Singh, N., Petitt, M., Dhal, S., Agrawal, R., Sutton, R.E., Druzin, M.L., Gambhir, S.S., Ambati, B.K., Cross, J.C., and Nayak, N.R. (2014). Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 124, 4941-4952.
24. Farina, A., Zucchini, C., De Sanctis, P., Morano, D., Sekizawa, A., Purwosunu, Y., Okai, T., and Rizzo, N. (2011). Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. Prenat Diagn 31, 181-185.
25. Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Marasco, E., Capranico, G., Mantovani, V., Marinello, J., Sabbioni, S., Callegari, E., Cescon, M., Ravaioli, M., Croce, C.M., Bolondi, L., and Gramantieri, L. (2012). In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 227, 275-285.
26. Gharesi-Fard, B., Zolghadri, J., and Kamali-Sarvestani, E. (2010). Proteome differences of placenta between preeclampsia and normal pregnancy. Placenta 31, 121-125.
27. Gu, Y., Burlison, S.A., and Wang, Y. (2006). PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnancies. Placenta 27, 744-749.
28. Gu, Y., Lewis, D.F., Deere, K., Groome, L.J., and Wang, Y. (2008). Elevated maternal IL-16 levels, enhanced IL-16 expressions in endothelium and leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia. J Immunol 181, 4418-4422.
29. Guo, L., Yang, Q., Lu, J., Li, H., Ge, Q., Gu, W., Bai, Y., and Lu, Z. (2011). A comprehensive survey of miRNA repertoire and 3 addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing. PLoS One 6, e21072.
30. Han, J.Y., Kim, Y.S., Cho, G.J., Roh, G.S., Kim, H.J., Choi, W.J., Paik, W.Y., Rho, G.J., Kang, S.S., and Choi, W.S. (2006). Altered gene expression of caspase-10, death receptor-3 and IGFBP-3 in preeclamptic placentas. Mol Cells 22, 168-174.
31. Higashijima, A., Miura, K., Mishima, H., Kinoshita, A., Jo, O., Abe, S., Hasegawa, Y., Miura, S., Yamasaki, K., Yoshida, A., Yoshiura, K., and Masuzaki, H. (2013). Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat Diagn 33, 214-222.
32. Hromadnikova, I. (2012). Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency. DNA Cell Biol 31, 1221-1232.
33. Hromadnikova, I., Dvorakova, L., Kotlabova, K., Kestlerova, A., Hympanova, L., Novotna, V., Doucha, J., and Krofta, L. (2015). Assessment of placental and maternal stress responses in patients with pregnancy related complications via monitoring of heat shock protein mRNA levels. Mol Biol Rep 42, 625-637.
34. Hromadnikova, I., Kotlabova, K., Doucha, J., Dlouha, K., and Krofta, L. (2012). Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications. J Mol Diagn 14, 160-167.
35. Hromadnikova, I., Kotlabova, K., Ondrackova, M., Kestlerova, A., Novotna, V., Hympanova, L., Doucha, J., and Krofta, L. (2013). Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm 2013, 186041.
36. Hsu, S.D., Chu, C.H., Tsou, A.P., Chen, S.J., Chen, H.C., Hsu, P.W., Wong, Y.H., Chen, Y.H., Chen, G.H., and Huang, H.D. (2008). miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res 36, D165-D169.
37. Hu, Y., Li, P., Hao, S., Liu, L., Zhao, J., and Hou, Y. (2009). Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47, 923-929.
38. Huang, Y., Chuang, A., Hao, H., Talbot, C., Sen, T., Trink, B., Sidransky, D., and Ratovitski, E. (2011). Phospho-DNp63a is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ 18, 1220-1230.
39. Huppertz, B. (2008). Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51, 970-975.
40. Huppertz, B., and Kingdom, J.C. (2004). Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Investig 11, 353-362.
41. Hwang, H.S., Kwon, H.S., Sohn, I.S., Park, Y.W., and Kim, Y.H. (2012). Increased CXCL12 expression in the placentae of women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 160, 137-141.
42. Ishibashi, O., Ohkuchi, A., Ali, M.M., Kurashina, R., Luo, S.S., Ishikawa, T., Takizawa, T., Hirashima, C., Takahashi, K., Migita, M., Ishikawa, G., Yoneyama, K., Asakura, H., Izumi, A., Matsubara, S., Takeshita, T., and Takizawa, T. (2012). Hydroxysteroid (17-b) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension 59, 265-273.
43. Ishioka, S., Ezaka, Y., Umemura, K., Hayashi, T., Endo, T., and Saito, T. (2006). Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells. Int J Med Sci 4, 36-44.
44. Khan, K.S., Wojdyla, D., Say, L., Gülmezoglu, A.M., and van Look, P.F. (2006). WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066-1074.
45. Khong, T.Y., De Wolf, F., Robertson, W.B., and Brosens, I. (1986). Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by smallfor-gestational age infants. Br J Obstet Gynaecol 93, 1049-1059.
46. Kotlabova,K.,Doucha, J., andHromadnikova, I. (2011). Placentalspecific microRNA in maternal circulation-identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 89, 185-191.
47. Lai, E.C. (2002). Micro RNAs are complementary to 3 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30, 363-364.
48. Lamarca, B. (2012). Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during preeclampsia. Minerva Ginecol 64, 309-320.
49. Li, P., Guo, W., Du, L., Zhao, J., Wang, Y., Liu, L., Hu, Y., and Hou, Y. (2013). microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin Sci (Lond) 124, 27-40.
50. Li, Q.J., Chau, J., Ebert, P.J., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., Klein, L.O., Davis, M.M., and Chen, C.Z. (2007). miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161.
51. Liang, Y., Ridzon, D., Wong, L., and Chen, C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8, 166.
52. Lim, R., Barker, G., and Lappas, M. (2014). The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-kB-dependent signalling. Am J Reprod Immunol 71, 401-417.
53. Lin, S., Cheung, W.K., Chen, S., Lu, G., Wang, Z., Xie, D., Li, K., Lin, M.C., and Kung, H.F. (2010). Computational identification and characterization of primate-specific microRNAs in human genome. Comput Biol Chem 34, 232-241.
54. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
55. Lockwood, C.J., Yen, C.F., Basar, M., Kayisli, U.A., Martel, M., Buhimschi, I., Buhimschi, C., Huang, S.J., Krikun, G., and Schatz, F. (2008). Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 172, 1571-1579.
56. Maccani, M.A., Padbury, J.F., and Marsit, C.J. (2011). miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS One 6, e21210.
57. Martinelli, R., Nardelli, C., Pilone, V., Buonomo, T., Liguori, R., Castanò, I., Buono, P., Masone, S., Persico, G., Forestieri, P., Pastore, L., and Sacchetti, L. (2010). miR-519d overexpression is associated with human obesity. Obesity (Silver Spring) 18, 2170-2176.
58. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E., Epstein, F.H., Sukhatme, V.P., and Karumanchi, S.A. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111, 649-658.
59. Mayor-Lynn, K., Toloubeydokhti, T., Cruz, A.C., and Chegini, N. (2011). Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 18, 46-56.
60. Mellembakken, J.R., Aukrust, P., Olafsen, M.K., Ueland, T., Hestdal, K., and Videm, V. (2002). Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension 39, 155-160.
61. Meng, T., Chen, H.Y., Li, J., and Shang, T. (2008). Expression of lectin-liked oxidized low density lipoprotein receptor-1 and apoptosis associated genes in placenta and the relationship thereof with morbility of early-onset preeclampsia. Zhonghua Yi Xue Za Zhi 88, 2633-2635.
62. Miko, E., Meggyes, M., Bogar, B., Schmitz, N., Barakonyi, A., Varnagy, A., Farkas, B., Tamas, P., Bodis, J., Szekeres-Bartho, J., Illes, Z., and Szereday, L. (2013). Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia. PLoS One 8, e71811.
63. Morales-Prieto, D.M., Ospina-Prieto, S., Chaiwangyen, W., Schoenleben, M., and Markert, U.R. (2013). Pregnancyassociated miRNA-clusters. J Reprod Immunol 97, 51-61.
64. Neale, D.M., and Mor, G. (2005).The role of Fas mediated apoptosis in preeclampsia. J Perinat Med 33, 471-477.
65. Nelson, D.M. (1996). Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 17, 387-391.
66. Noack, F., Ribbat-Idel, J., Thorns, C., Chiriac, A., Axt-Fliedner, R., Diedrich, K., and Feller, A.C. (2011). miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J Perinat Med 39, 267-271.
67. O'Connell, R.M., Taganov, K.D., Boldin, M.P., Cheng, G., and Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104, 1604-1609.
68. Orozco, A.F., Bischoff, F.Z., Horne, C., Popek, E., Simpson, J.L., and Lewis, D.E. (2006). Hypoxia-induced membranebound apoptotic DNA particles: potential mechanism of fetal DNA in maternal plasma. Ann N Y Acad Sci 1075, 57-62.
69. Oudejans, C.B., Tjoa, M.L., Westerman, B.A., Mulders, M.A., van Wijk, I.J., and van Vugt, J.M. (2003). Circulating trophoblast in maternal blood. Prenatal Diagn 23, 111-116.
70. Pineles, B.L., Romero, R., Montenegro, D., Tarca, A.L., Han, Y.M., Kim, Y.M., Draghici, S., Espinoza, J., Kusanovic, J.P., Mittal, P., Hassan, S.S., and Kim, C.J. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196, 261.e261-e266.
71. Poon, L.C., Akolekar, R., Lachmann, R., Beta, J., and Nicolaides, K.H. (2010). Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 35, 662-670.
72. Prins, J.R., Faas, M.M., Melgert, B.N., Huitema, S., Timmer, A., Hylkema, M.N., and Erwich, J.J. (2012). Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction. Placenta 33, 453-455.
73. Redman, C.W., Sacks, G.P., and Sargent, I.L. (1999). Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180, 499-506.
74. Reid, G.J., Flozak, A.S., and Simmons, R.A. (2002). Placental expression of insulin-like growth factor receptor-1 and insulin receptor in the growth-restricted fetal rat. J Soc Gynecol Investig 9, 210-214.
75. Roberts, J.M., and Hubel, C.A. (2009). The two stage model of preeclampsia: variations on the theme. Placenta 30 Suppl A, S32-S37.
76. Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., Benjamin, H., Shabes, N., Tabak, S., Levy, A., Lebanony, D., Goren, Y., Silberschein, E., Targan, N., Ben-Ari, A., Gilad, S., Sion-Vardy, N., Tobar, A., Feinmesser, M., Kharenko, O., Nativ, O., Nass, D., Perelman, M., Yosepovich, A., Shalmon, B., Polak-Charcon, S., Fridman, E., Avniel, A., Bentwich, I., Bentwich, Z., Cohen, D., Chajut, A., and Barshack, I. (2008). MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26, 462-469.
77. Schmitz, U., Wolkenhauer, O., and Vera, J. (2013). MicroRNA Cancer Regulation: Advanced Concepts, Bioinformatics and Systems Biology Tools (Springer Science & Business Media, Berlin), ISBN 9400755902.
78. Seitz, H., Royo, H., Bortolin, M.L., Lin, S.P., Ferguson-Smith, A.C., and Cavaillé, J. (2004). A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14, 1741-1748.
79. Sezer, S.D., Küçük, M., Döger, F.K., Yüksel, H., Odabasxi, A.R., Türkmen, M.K., Cakmak, B.Cx., Ömürlü, I.K., and Kinasx, M.G. (2013). VEGF, PIGF and HIF-1a in placentas of earlyand late-onset pre-eclamptic patients. Gynecol Endocrinol 29, 797-800.
80. Shang, L.X., Wang, J., Zhang, L.J., Gao, H., Qu, D.Y., and Wang, J.H. (2005). Relationship between changes of insulin like growth factor-1 and insulin like growth factor binding protein-1 in maternal serum and placenta and pathogenesis of hypertensive disorder complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 40, 516-520.
81. Sharp, A.N., Heazell, A.E., Baczyk, D., Dunk, C.E., Lacey, H.A., Jones, C.J., Perkins, J.E., Kingdom, J.C., Baker, P.N., and Crocker, I.P. (2014). Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast. PLoS One 9, e87621.
82. Stepan, H., Leo, C., Purz, S., Höckel, M., and Horn, L.C. (2005). Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 122, 172-176.
83. Tal, R. (2012). The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 87, 134.
84. Teng, Y., Jiang, R., Lin, Q., Ding, C., and Ye, Z. (2010). The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thromb Res 126, e41-e45.
85. Tili, E., Michaille, J.J., Cimino, A., Costinean, S., Dumitru, C.D., Adair, B., Fabbri, M., Alder, H., Liu, C.G., Calin, G.A., and Croce, C.M. (2007). Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179, 5082-5089.
86. Todros, T., Marzioni, D., Lorenzi, T., Piccoli, E., Capparuccia, L., Perugini, V., Cardaropoli, S., Romagnoli, R., Gesuita, R., Rolfo, A., Paulesu, L., and Castellucci, M. (2007). Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. Placenta 28, 1123-1132.
87. Tosun, M., Celik, H., Avci, B., Yavuz, E., Alper, T., and Malatyalioglu, E. (2010). Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 23, 880-886.
88. Valensise, H., Vasapollo, B., Gagliardi, G., and Novelli, G.P. (2008). Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52, 873-880.
89. von Dadelszen, P., Magee, L.A., and Roberts, J.M. (2003). Subclassification of preeclampsia. Hypertens Pregnancy 22, 143-148.
90. Wang, X., and El Naqa, I.M. (2008). Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332.
91. Wataba, K., Saito, T., Takeuchi, M., Nakayama, M., Suehara, N., and Kudo, R. (2004). Changed expression of heat shock proteins in various pathological findings in placentas with intrauterine fetal growth restriction. Med Electron Microsc 37, 170-176.
92. Whitehead, C.L., Walker, S.P., Lappas, M., and Tong, S. (2013). Circulating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia. J Perinatol 33, 600-604.
93. WHO (1988) Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol 158, 80-83.
94. Wieser, F., Waite, L., Depoix, C., and Taylor, R.N. (2008). PPAR Action in Human Placental Development and Pregnancy and Its Complications. PPAR Res 2008, 527048.
95. Wilczyński, J.R., Tchórzewski, H., G1owacka, E., Banasik, M., Lewkowicz, P., Szpakowski, M., Zeman, K., and Wilczyński, J. (2002). Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm 11, 105-111.
96. Xie, F., Hu, Y., Turvey, S.E., Magee, L.A., Brunham, R.M., Choi, K.C., Krajden, M., Leung, P.C., Money, D.M., Patrick, D.M., Thomas, E., and von Dadelszen, P. (2010). Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia. BJOG 117, 99-108.
97. Xu, P., Zhao, Y., Liu, M., Wang, Y., Wang, H., Li, Y.X., Zhu, X., Yao, Y., Wang, H., Qiao, J., Ji, L., and Wang, Y.L. (2014). Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension 63, 1276-1284.
98. Ye, W., Lv, Q., Wong, C.K., Hu, S., Fu, C., Hua, Z., Cai, G., Li, G., Yang, B.B., and Zhang, Y. (2008). The effect of central loops in miRNA: MRE duplexes on the efficiency of miRNAmediated gene regulation. PLoS One 3, e1719.
99. Yoshitomi, T., Kawakami, K., Enokida, H., Chiyomaru, T., Kagara, I., Tatarano, S., Yoshino, H., Arimura, H., Nishiyama, K., Seki, N., and Nakagawa, M. (2011). Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. Oncol Rep 25, 1661-1668.
100. Zhang, Y., Diao, Z., Su, L., Sun, H., Li, R., Cui, H., and Hu, Y. (2010). MicroRNA-155 contributes to preeclampsia by downregulating CYR61. Am J Obstet Gynecol 202, 466.e461-e467.
101. Zhou, P., Luo, X., Qi, H.B., Zong, W.J., Zhang, H., Liu, D.D., and Li, Q.S. (2012). The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res 61, 1005-1012.
102. Zhu, X.M., Han, T., Sargent, I.L., Yin, G.W., and Yao, Y.Q. (2009). Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200, 661.e661-e667.